Fundraising FoxMegakaryon
Kyoto, JP · 8 known investors
Find your way into Megakaryon
Sign up to see every warm intro you have to Megakaryon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Megakaryon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications. The company operates through collaborative research partnerships with academic institutions and pharmaceutical manufacturers in Japan and internationally.
Investors · 8
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Megakaryon do?
- Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications. The company operates through collaborative research partnerships with academic institutions and pharmaceutical manufacturers in Japan and internationally.
- Who are Megakaryon's investors?
- Megakaryon's investors include Miyako Capital, DBJ Capital, Japan Asia Investment, KSP, Inc., Mitsubishi UFJ Capital, Mizuho Capital, Nissay Capital, SMBC Venture Capital.
- Where is Megakaryon headquartered?
- Megakaryon is headquartered in Kyoto, JP.